Jeanette K Doorduijn

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 15

Top Topics

Cerebrospinal Fluid

Newly Diagnosed

Chronic Lymphocytic Leukemia

Stem Cell Transplantation

Top Venues

Journal of neurology

Blood cancer journal

British journal of haematology

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. Blood cancer journal 13 (1) (2023)
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. Blood cancer journal 13 (1) (2023)
Myrthe E de Koning, Jurrit J Hof, Casper Jansen, Jeanette K Doorduijn, Jacoline E C Bromberg, Matthijs van der Meulen
Primary central nervous system lymphoma. Journal of neurology 271 (5) (2023)
Myrthe E de Koning, Jurrit J Hof, Casper Jansen, Jeanette K Doorduijn, Jacoline E C Bromberg, Matthijs van der Meulen
Primary central nervous system lymphoma. Journal of neurology 271 (5) (2023)
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. Blood cancer journal 13 (1) (2023)
Jacoline E C Bromberg, Samar Issa, Bronno van der Holt, Matthijs van der Meulen, Linda Dirven, Monique C Minnema, Tatjana Seute, Marc Durian, Gavin Cull, Marjolein W M van der Poel, Wendy Bernadina Catharina Stevens, Josee M Zijlstra, Dieta Brandsma, Marcel Nijland, Kylie D Mason, Aart Beeker, Martine C J Abrahamse-Testroote, Martin J Van Den Bent, Daphne de Jong, Jeanette K Doorduijn
Survival, Neurocognitive Function and Health-Related Quality of life outcomes after (R-)MBVP for PCNSL: Final Results of the HOVON 105 / ALLG NHL 24 Study. Neuro-oncology (2023)
Myrthe E de Koning, Jurrit J Hof, Casper Jansen, Jeanette K Doorduijn, Jacoline E C Bromberg, Matthijs van der Meulen
Primary central nervous system lymphoma. Journal of neurology (2023)
Lina van der Straten, Mark-David Levin, Manette A W Dinnessen, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Anton W Langerak, Arnon P Kater, Avinash G Dinmohamed
Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019. Blood cancer journal 13 (1) (2023)
Myrthe E de Koning, Jurrit J Hof, Casper Jansen, Jeanette K Doorduijn, Jacoline E C Bromberg, Matthijs van der Meulen
Primary central nervous system lymphoma. Journal of neurology 271 (5) (2023)
Myrthe E de Koning, Jurrit J Hof, Casper Jansen, Jeanette K Doorduijn, Jacoline E C Bromberg, Matthijs van der Meulen
Primary central nervous system lymphoma. Journal of neurology 271 (5) (2023)
Lina van der Straten, Mark-David Levin, Otto Visser, Eduardus F M Posthuma, Jeanette K Doorduijn, Arnon P Kater, Avinash G Dinmohamed
Conditional relative survival among patients with chronic lymphocytic leukaemia: A population-based study in the Netherlands. EJHaem 3 (1) (2021)
Marie José Kersten, Karima Amaador, Monique C Minnema, Josephine M I Vos, Kazem Nasserinejad, Marcel Kap, Efstathios Kastritis, Maria Gavriatopoulou, Willem Kraan, Martine E D Chamuleau, Dries Deeren, Lidwine W Tick, Jeanette K Doorduijn, Fritz Offner, Lara H Böhmer, Roberto D Liu, Steven T Pals, Meletios- Athanasios Dimopoulos
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Jacoline E C Bromberg, Matthijs van der Meulen, Jeanette K Doorduijn
The Role of Rituximab in Primary Central Nervous System Lymphoma. Current oncology reports 22 (8) (2020)
Jeanette K Doorduijn, Josee M Zijlstra, Pieternella J Lugtenburg, Marie Josee Kersten, Lara H Böhmer, Monique C Minnema, Marius A MacKenzie, Rien van Marwijk Kooij, Eva de Jongh, Tjeerd J F Snijders, Okke de Weerdt, Michel van Gelder, Mels Hoogendoorn, Rineke B L Leys, Robby E Kibbelaar, Daphne de Jong, Dana A Chitu, Mars B Van't Veer, Hanneke C Kluin-Nelemans
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial. British journal of haematology 190 (3) (2020)
Lina van der Straten, Mark-David Levin, Otto Visser, Nicole M A Blijlevens, Jan J Cornelissen, Jeanette K Doorduijn, Arnon P Kater, Avinash G Dinmohamed
The effectiveness of ibrutinib in chronic lymphocytic leukaemia: a nationwide, population-based study in the Netherlands. British journal of haematology 188 (6) (2020)